Potentials of contemporary biomarkers in assessing skin lesions and fibrous activity in systemic scleroderma
Journal Title: Український журнал дерматології, венерології, косметології - Year 2019, Vol 0, Issue 3
Abstract
Systemic scleroderma (SSD) is a systemic disease with heterogeneous clinical manifestations of skin and internal organs lesions. It is believed that the trigger for its development is the initial damage of the blood vessels leading to an inflammatory reaction and accumulation of collagen and other extracellular matrix components. One of the important aspects of managing these patients is the identification of patients with a high risk of internal organ and skin damage and control of fibrotic activity in response to therapy. Diagnosis and control of skin lesions in SSD is performed by clinical observation and the use of methods such as skin count on the Rodnan scale (mRSS), durometry, goniometry, and ultrasonic skin thickness determination. However, the sensitivity of these methods is quite low, they are not validated for use at present and are rather laborious and subjective. In addition, these methods do not provide information about the fibrotic activity. These disadvantages of the above mentioned methods can be compensated by studying the biomarkers of skin lesions in SSD which reflect not only the inflammatory and fibrotic activity, but also can be used for evaluating the prognosis and effectiveness of the treatment. This review focuses on biomarkers of skin lesions in patients with scleroderma. These include the growth factors, cytokines and proteases, their inhibitors, as well as some proteins of the extracellular matrix, especially collagens, which were identified in skin biopsies and in serum samples of patients with SSD. The review summarizes noninvasive physical and laboratory studies that provide a better understanding of the fibrotic activity of the disease, can be effectively used to evaluate a potential therapeutic response and find best treatment options for patients with SSD.
Authors and Affiliations
I. Yu. Golovach, Ye. D. Yehudina
Keywords
Related Articles
- EP ID EP672781
- DOI 10.30978/UJDVK2019-3-113
- Views 84
- Downloads 0
Potentials of contemporary biomarkers in assessing skin lesions and fibrous activity in systemic scleroderma
Systemic scleroderma (SSD) is a systemic disease with heterogeneous clinical manifestations of skin and internal organs lesions. It is believed that the trigger for its development is the initial damage of the blood vess...
Features of the treatment of chronic generalized catarrhal gingivatis in the young patients with prebiotic Lequin
Objective — study the therapeutic effect of Lequin in the complex treatment of young patients with chronic generalized catarrhal gingivitis. Materials and methods. Under our supervision were 15 young patients with chron...
Epidermolysis bullosa: treatment and prevention
Congenital epidermolysis bullosa is considered as a phenotypically and genetically heterogeneous group of genodermatoses caused by various mutations in the genes that control the synthesis of structural proteins of the s...
Impact of clinical course of epidermolysis bullosis on quality of life of patients in Ukraine
Objective — to determine the impact of the severity of epidermolysis bullosa (EB) on the quality of life (QL) of patients with this disease. Materials and methods. The work was performed at the Department of Dermatology...
Verrucous psoriasis: clinical case
Case of rare clinical form of psoriasis — verrucous psoriasis — is described. Diagnostic mistakes and results of differential diagnostics are presented.